Hong, J., Shen, Y. A., Hsu, C. Y., Huang, P., Tomaszewski, A., Gabrielson, E., … Wang, T. L. (2022). Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC). Genes and Diseases, 9(6), 1408–1411. https://doi.org/10.1016/j.gendis.2022.02.009

Hong, J., Y. A. Shen, C. Y. Hsu, P. Huang, A. Tomaszewski, E. Gabrielson, I. M. Shih, S. Gaillard, and T. L. Wang. “Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC).” Genes and Diseases 9, no. 6 (November 1, 2022): 1408–11. https://doi.org/10.1016/j.gendis.2022.02.009.

Hong J, Shen YA, Hsu CY, Huang P, Tomaszewski A, Gabrielson E, et al. Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC). Genes and Diseases. 2022 Nov 1;9(6):1408–11.

Hong, J., et al. “Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC).” Genes and Diseases, vol. 9, no. 6, Nov. 2022, pp. 1408–11. Scopus, doi:10.1016/j.gendis.2022.02.009.

Hong J, Shen YA, Hsu CY, Huang P, Tomaszewski A, Gabrielson E, Shih IM, Gaillard S, Wang TL. Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC). Genes and Diseases. 2022 Nov 1;9(6):1408–1411.